Daha iyi bir deneyim için konum izni vermelisiniz.
MENU
ÖZGEÇMİŞ
BİLİMSEL YAYINLAR
EĞİTİM
  • 2013 Uludağ Üniversitesi / Farmakoloji / Doktora
  • 2001 Uludağ Üniversitesi Tıp Fakültesi Tıbbi Onkoloji
  • 2000 Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları
  • 1995 Ondokuzmayıs Üniversitesi Tıp Fakültesi
İŞ DENEYİMİ
  • 2019 - Halen Acıbadem Sağlık Grubu
  • 2012 Vall d''Hebron Institute of Oncology Gastrointestinal and Phase I units / Barselona (Prof. Joseph Tabernero ile birlikte)
  • 2011 - 2011 Fox Chase Cancer Center Philadelphia Externship Organization
  • 2011 - 2011 The University of North Carolina at Chapel Hill Cancer Hospital / Gastrointestinal Cancer Unit (Prof. Bert O?Neil ve Prof. Richard Goldberg ile birlikte)
  • 2011 - 2011 Memorial Sloan Kettering Cancer Center / Gastrointestinal Cancer Unit (Prof. Nancy Kemeny ile birlikte) / New York, Amerika Birleşik Devletleri
  • 1995 - 2019 Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları ABD / Tıbbi Onkoloji Bilim Dalı
BİLİMSEL YAYINLAR
  • Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status World J Clin Cases. 2018 Oct 6;6(11):418-425. doi: 10.12998/wjcc.v6.i11.418. Review. Kanat O, Ertas H, Caner B.
  • Shattering the castle walls: Anti-stromal therapy for pancreatic cancer World J Gastrointest Oncol. 2018 Aug 15;10(8):202-210. doi: 10.4251/wjgo.v10.i8.202. Review. Kanat O, Ertas H.
  • Platinum-induced neurotoxicity: A review of possible mechanisms World J Clin Oncol. 2017 Aug 10;8(4):329-335. doi: 10.5306/wjco.v8.i4.329. Review. Kanat O, Ertas H, Caner B.
  • Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma : implications for clinicopathology and patient outcomes Acta Gastroenterol Belg. 2017 Jan-Mar;80(1):31-37. Uğraş N, Yerci Ö, Özgün G, Deligönül A, Dündar HZ, Sarkut P, Kanat Ö.
  • Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer J BUON. 2016 May-Jun;21(3):564-9 Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, Hartavi M, Fatih Olmez O, Kurt E, Tolunay S, Kanat O, Manavoglu O.
  • Current treatment options for patients with initially unresectable isolated colorectal liver metastases World J Clin Oncol. 2016 Feb 10;7(1):9-14. doi: 10.5306/wjco.v7.i1.9. Kanat O.
  • Distribution of KRAS and BRAF Mutations in Metastatic Colorectal Cancers in Turkish Patients Asian Pac J Cancer Prev. 2016;17(3):1175-9. Gorukmez O, Yakut T, Gorukmez O, Sag SO, Karkucak M, Kanat O.
  • Targeted therapy for advanced gastric cancer: A review of current status and future prospects World J Gastrointest Oncol. 2015 Dec 15;7(12):401-10. doi: 10.4251/wjgo.v7.i12.401. Review. Kanat O, O''Neil B, Shahda S.
  • linical significance of adiponectin expression in colon cancer patients J Cancer Res Ther. 2014 Apr-Jun;10(2):347-53. doi: 10.4103/0973-1482.136634. Canhoroz M, Kanat O, Saraydaroglu O, Buluc E, Avci N, Cubukcu E, Olmez OF, Manavoglu O.
  • Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454. Epub 2014 Feb 28. Cubukcu E, Olmez OF, Kanat O, Kabul S, Canhoroz M, Avci N, Hartavi M, Deligonul A, Cubukçu S, Manavoglu O.
Daha iyi bir deneyim için konum izni vermelisiniz.
Size nasıl yardımcı olabiliriz?